In Brief: Bufferin low-dose caplets
This article was originally published in The Tan Sheet
Executive Summary
Bufferin low-dose caplets: Bristol-Myers Squibb plans to drop an FSI for its low-dose (81 mg) aspirin product in October, following an FSI that ran in newspapers on July 27 and included a $1-off coupon. The FSIs mark BMS' first advertising effort for the "adult regimen strength" Bufferin line extension. Launched to the trade in February, low-dose Bufferin, "designed specially for people on an aspirin regimen or as directed by your doctor," has a "pH sensitive enteric coating" that does not dissolve until it reaches the small intestine, the company says. A 140-count bottle retails for $5.49. Other Bufferin products are available in 325 mg (Regular Strength) and 500 mg (Extra Strength) dosages...